Cargando…
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
Eating disorders (EDs) are serious, life-threatening psychiatric conditions associated with physical and psychosocial impairment, as well as high morbidity and mortality. Given the chronic refractory nature of EDs and the paucity of evidence-based treatments, there is a pressing need to identify nov...
Autores principales: | Ragnhildstveit, Anya, Slayton, Matthew, Jackson, Laura Kate, Brendle, Madeline, Ahuja, Sachin, Holle, Willis, Moore, Claire, Sollars, Kellie, Seli, Paul, Robison, Reid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963252/ https://www.ncbi.nlm.nih.gov/pubmed/35326338 http://dx.doi.org/10.3390/brainsci12030382 |
Ejemplares similares
-
Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study
por: Ahuja, Sachin, et al.
Publicado: (2022) -
A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders
por: Robison, Reid, et al.
Publicado: (2022) -
Breathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review
por: Banushi, Blerida, et al.
Publicado: (2023) -
Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
por: Keeler, Johanna Louise, et al.
Publicado: (2023) -
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report
por: Ragnhildstveit, Anya, et al.
Publicado: (2023)